Imbalance in the network of soluble mediators may play a pivotal role in the pathogenesis of Kaposi's sarcoma (KS). 
the most common cancer affecting HIV-1-infected individuals. Unlike the more indolent endemic and sporadic form of KS, the disease is usually aggressive and unpredictable in individuals infected by HIV-1, and the neoplasm is the cause of significant morbidity and occasional mortality (1, 2) . KS is now treated with cytostatic drugs, cytokines, or radiotherapy to control cell proliferation (3) (4) (5) (6) . Sulfated polysaccharide peptidoglycans control the in vitro growth of KS cells and the in vivo angiogenic response without cytotoxic effect (7) .
KS is composed of spindle-shaped cells, vascular smooth muscle cells (VSMC), endothelial cells (EC), and fibroblasts. The early phase of disease is characterized by an infiltrate of leukocytes and a prominent angiogenesis, which is crucial to the growth and progression of KS (8) (9) (10) (11) (12) . The current hypothesis to explain the behavior of KS is an imbalance in the network of soluble mediators caused by HIV-1, other viruses, immunosuppressive treatment, or genetic factors (13) (14) (15) (16) (17) (18) . The tat transgenic mice develop lesions similar to KS ( 19) , suggesting that this viral protein can be a factor which triggers the imbalance in the network of soluble mediators.
The introduction of routine cell culture of KS-derived spindle cells (20) (21) (22) (23) has made it possible to demonstrate that they produce and respond to various soluble mediators ( 19, (24) (25) (26) (27) (28) (29) (30) . Oncostatin M (27, 28), IL-6 (25), IL-1 (24) , and GM-CSF (30) , as well as Tat protein (29) , stimulate KS cell growth in vitro. Also, KS cells produce factors that stimulate their own chemotactic activity and the proliferation and migration of EC (31, 32) . Furthermore, KS cells or conditioned medium from KS cells induces a marked angiogenic response in mice or in chicken chorioallantoic membrane (33, 34) . Fibroblast growth factor (FGF) (35) (36) (37) (38) , PDGF (26) , vascular endothelial growth factor (VEGF) (39) , and hepatocyte growth factor (HGF) (40) , produced by KS cells, and other unknown factor(s) (32) have been postulated to be involved in angiogenesis in KS.
Platelet activating factor (PAF) is a phospholipid mediator of inflammation and cell-to-cell communications that belongs to the structurally related family of acetylated phosphoglycerides (for reviews see references [41] [42] [43] . PAF is produced by stimulated inflammatory cells (for reviews see references [41] [42] [43] , EC (44) (45) (46) (47) (48) , and T cells (49) and acts through a G protein-coupled receptor, which has been cloned recently (50, 51 ) . PAF possesses pleiotropic activities at nanomolar concentrations, including platelet activation, contraction of smooth muscle, chemotaxis and granule secretion of neutrophils and macrophages, and synthesis of IL-1 and TNF by macrophages (for reviews see references [41] [42] [43] . Also VSMC (52) and EC are relevant targets for PAF (53) (54) (55) . PAF activates EC, modifying their adhesive properties for circulating cells (56) and inducing rearrangement of cytoskeletal structure (53, 55) .
The aim of this study was to evaluate whether KS cells can produce and respond to PAF. The results obtained indicate that PAF is synthesized by KS cells and that it is instrumental in the in vitro migration of KS cells and the in vivo angiogenic response.
Methods
Materials. 1-O-octadecyl-2-acetyl-(R)-glycero-3-phosphocholine (PAF), 1-O-octadecyl-2-lyso-sn-glycero-3-phosphocholine, and PDGF were from Bachem Feinkemikalien (Bubendorf, Switzerland); 1-0-hexadecyl-2-N-methylcarbamyl-sn-glycero-3-phosphocholine (C-PAF) was from Cascade Biochem Ltd. (Berkshire, United Kingdom); 1-0-[3H]-octadecyl-2-acetyl-sn-glycero-3-phosphocholine (130 Ci/mmol) and [a-32P]dCTP (3,000 Ci/mmol) were from Amersham International (Buckinghamshire, United Kingdom); IL-la and oncostatin M were from Immunex (Seattle, WA); TNF was from Genentech, Inc. (South, San Francisco, CA); WEB 2170 (8-(-)6-(2-chlorophenyl)-8,9 dihydro-l-methyl-8 [(4-morpholinyl)carbonyl]-4H, 7H-cyclopenta [4, 5] thieno [3,2,- biopsies of two HIV-seropositive patients and one patient with a sporadic form of KS (HIV negative) and maintained as described previously (23) . The cultures were named AIDS-IST-KS3, AIDS-IST-KS4, IST-KS8, and AIDS-IST-KSII, respectively (abbreviated to KS3, KS4 , KS8, and KS1 1). Cells had the elongated morphological aspect typical of spindle-shaped KS cells (20) (21) (22) 25) ; immunohistochemical characterization showed positivity for vimentin, collagen I, laminin, smooth muscle actin, and desmin, but not for CD45, von Willebrand factor, and EN4 antigen, in agreement with previous reports (20, 25, 58, 59 ) and as already described (23) . Cells were grown on plastic surface coated with gelatin in RPMI 1640 containing 20% FCS supplemented with amino acids and 0.5% Ultroser HY. Cultures were used at passages 4-15, and the day before the experiments 50% of medium was renewed. EC from human umbilical cord vein were prepared, grown, and characterized as described previously (46, 60) . Human myelomonocytic U937 cells and human megakaryoblastic M07 cells were maintained in RPMI 1640 medium with 10% FCS (a gift of Dr. L. Pegoraro, Torino, Italy). Human VSMC (kind gift from Dr. M. Trovati, Torino. Italy), J774 murine macrophage cell line, and MDCK cells were maintained in DME containing 10% FCS, 10 mM Hepes, and 10 mM N-Tris-(hydroxymethyl) methyl-2-aminoethanesulfonic acid (pH 7.4). Human PMN were prepared as described previously (61) .
Conditioned medium (CM) was prepared from KS (KS-CM) as follows: cells were grown to confluence in 150-cm2 dishes and then incubated for 48 h with Iscove's medium containing 0.45% BSA (LPSfree) (GIBCO-BRL). CM from EC (EC-CM) was prepared as above, but Iscove's medium also contained 6 mg/liter transferrin, 5 mg/liter insulin, 100 mg/liter soybean lecithin, and 6.73 mg/liter sodium selenite. CM from J774, MDCK, and M07 cell lines and VSMC were prepared in a similar way in Iscove's medium. The cell viability assessed by trypan blue exclusion was > 90%. The medium was centrifuged and used immediately or 10-fold-concentrated by a sterilized Centricon 10 filter (Amicon, Inc., Beverly, MA) precoated with 0.25% BSA (LPSfree) solution and stored at -80°C.
PAF production. KS cells grown to confluence on 35-mm-diameter Petri dishes (3 X104/cm2) were washed twice with RPMI 1640 medium containing 20 mM Hepes (pH 7.4) and 0.25% BSA (LPS-free) and incubated in 5% CO2 for the indicated times with different concentrations of human recombinant IL-la, TNF-a, and thrombin (Thr). PAF released into the medium and cell-associated PAF was extracted, purified by TLC, and measured by washed rabbit platelet aggregation as described (44, 46, 61) . PAF was also extracted, purified, and quantified from the plasma (62) of two Caucasian subjects affected by classic KS and the amounts detected were 0.7 and 1.3 pmol/ml, respectively. Biologically active PAF has been characterized on the basis of its physicochemical and chromatographic characteristics and sensitivity to lipases (44, 46, 61, 62 Chemotaxis assay. Chemotaxis assays were performed as described previously (60) using the Boyden chamber technique. Polycarbonate filters (5-pm pore size, polyvinylpyrrolidone-free; Nucleopore Corp., Pleasanton, CA) were coated with gelatin (Difco Laboratories, Detroit, MI) (0.1 % for 6 h at room temperature). Chemotactic agents in specific medium used to culture KS cells, EC, VSMC, and J774 cells supplemented with 0.25% BSA (LPS-free) were placed in the lower compart-ment of the chamber, and 2 x I05 suspended cells in medium containing 1% FCS were then seeded in the upper compartments. After 6 h of incubation at 370C, the upper surface of the filter was scraped with a rubber policeman. The filters were fixed and stained with Diff-Quick (Harleco, Gibbstown, NJ), and 10 oil immersion fields were counted after coding samples.
The directness of PAF-stimulated migration was evaluated using checkerboard analysis (63) . Increasing concentrations of PAF were placed in both top and bottom wells of the Boyden chamber to establish positive, absent, or negative concentration gradients across the filter barrier. Directed locomotion, chemotaxis, is the response to a net gradient of attractant; random stimulated migration, chemokinesis, is the response to attractant when no concentration gradient is present.
Cell growth assay. 1.5 X 103 cells were plated in 96-well plates coated with gelatin in specific growth medium indicated above. After 24 h, the medium was removed and replaced with specific medium containing 2.5% FCS. Stimuli indicated in Results were added at days 0, 2, 4, and 6 and cell number was estimated at day 8 by a colorimetric method as detailed previously (60) . Proportionality The PCR protocol for PAF-R, MIP-2, FGF-7, and KC cDNAs was as follows: 1 min at 940C, 1 min at 550C, I min at 720C for 30 cycles; 1 min at 940C, 1 min at 550C, 10 min at 72°C for the last cycle. For P1GF, K-FGF, FGF-6, and HGF cDNAs the PCR protocol was as follows: 1 min at 94°C, 1 min at 50°C, 1 min at 72°C for 30 cycles; 1 min at 940C, 1 min at 500C, 10 min at 720C for the last cycle. For VEGF and FGF-5 cDNAs the PCR protocol was as follows: 1 min at 940C, 2 min at 550C, 3 min at 720C for 30 cycles; I min at 940C, 2 min at 550C, 10 min at 720C for the last cycle. For JE and FGF-3 cDNAs the PCR protocol was as follows: 1 min at 94°C, 1 min at 450C, I min at 720C for 30 cycles; 1 min at 94°C, 1 min at 45°C, 10 min at 72°C for the last cycle. For aFGF and bFGF cDNAs the PCR protocol was as follows: 1 min at 94°C, 1 min at 550C, 1 min at 72°C for 35 cycles; 1 min at 940C, 1 min at 550C, 10 min at 72°C for the last cycle. RT-PCR of ,Bactin was performed by using specific oligonucleotides (Stratagene) with the following protocol: 1 min at 94°C, 1 min at 550C, I min at 72°C for 30 cycles; 1 min at 940C, 1 min at 55°C, 10 min at 72°C for the last cycle. 20 jA of the amplified solution was run in a 1.8% agarose gel electrophoresis in Tris-borate-EDTA buffer and stained with 0.5 g g/ ml ethidium bromide. The products of PCR were analyzed and identified by Southern blot analysis, except those of FGF-7. Specific cDNAs were labeled with [a-32P]dCTP (3,000 Ci/mmol; Amersham International) at 2.2 x 108 cpm/,ug specific activity, by the random primer labeling method (Megaprime DNA labeling system; Amersham International) according to the manufacturer's instructions. The gel was washed for 10 mm in 0.5 M NaOH + 1.5 M NaCl, 10 mm in 0.5 M Tris (pH 7.5) + 1.5 M NaCl and then blotted on a nylon Duralon-UV membrane. The membrane was prehybridized for 2 h and hybridized overnight at 57°C in a solution containing 5X Denhardt's, 6x SSC, 10% SDS, and 100 /.g/ml denatured salmon sperm DNA. Washes were carried out at high stringency (2x SSC + 0.1% SDS at 200C for 30 min, 0.5X SSC + 0.1% SDS at 570C for 30 min, and three times in 0.1x SSC + 0.1% SDS at 57°C for 30 min) and the membrane was exposed to Hyperfilm MP (Amersham International) with intensifying screens at -80°C for 3 d.
Results
Production of PAF by KS cells. The three KS cell lines studied produced a small quantity of PAF that, in short-term experiments, remained associated with the cells (Fig. 1) . However, when PAF was measured after 48 h of growth without FCS in (8) (9) (10) (11) (12) . We thus studied the effect of PAF on the migration and proliferation of KS cells, EC, VSMC, and macrophage murine cell line J774. PAF promoted in a dose-dependent manner the motility of KS cells, EC, VSMC, and J774 cells in the Boyden chamber. The motility response of three different cell types was maximal at PAF con- centrations ranging from 10 to 50 nM ( Fig. 2 and Table I ).
(S)-PAF ( Fig. 2) and lyso-PAF were ineffective (Table I) (Table III) . Since cell proliferation was studied in the presence of FCS, C-PAF, which is resistant to inactivation by acetylhydrolase (76), was used. C-PAF did not modify the basal growth of KS cells, EC, VSMC (Table IV) (Fig. 2 A) . Scatchard analysis indicated the presence of one class of binding sites and the resulting Kd was 128 (Fig. 2 B) , 98, and 140 pM, respectively, for KS3, KS4, and KS8 cells. The number of receptors per cell ranged from 450 ( Fig. 2 B) We examined also the capacity of confluent KS cells to express the specific transcript of PAF-R. RNA extracted from KS cells as well as from PMN and U937 cells, used as positive controls, was analyzed by RT-PCR using specific primers for PAF-R. Amplification of RNA extracted from KS cells and positive controls gave a band of 192 bp, which corresponds to the selected region of the PAF-R-cDNA (51 ) and was identified by Southern blot (Fig. 2 C) .
Role of PAF in angiogenesis induced by KS-CM and KS cells. Matrigel containing KS-CM was injected subcutaneously into mice, and the histologic and morphometric analysis of the plugs was performed on days 2, 5, 7, and 8 (Figs. 3 and 4) .
KS-CM had angiogenic activity in 83% of animals (10 positive implants out of 12; P < 0.001 by Fisher exact test) with the maximal vascularization scored at day 7 (Fig. 4 A) . CM from EC (Fig. 4 B) (Fig. 4 B) .
KS-CM induced penetration of von Willebrand factor-positive EC into the Matrigel (Fig. 5) . Canalization of vessels progressively increased in the following days with formation of linear or microaneurismatic structures containing circulating cells (Fig. 5 B) . An infiltration of macrophages (Mac-l -positive cells) was evident at day 2 (Table V) 16±5 8±6 21±3 10±6 14±2 9±6 17±4 PAF 10 nM 56±8* 39±2* 38±7* 31±6* 30±2* 29±2* 38±2* 30±7$ 32±4* 38±5* 34±6* 40±7* 22±3* 21±7 27±6* 20±5 PAF5OnM 67±6* 76±7* 78±15* 78±9* 80±5* 66±4* 18±5* 68±2* 40±10* 68±5* 37±6* 56±7* 42±2* 56±4* 32±4* 17±6 Checkerboard analysis was performed by the Boyden chamber technique as described in Methods by adding PAF in the upper and/or lower compartments of the chamber. Cells migrated after 6 h of incubation to the lower surface of the filter were counted after coding samples. * The numbers are the mean±SD of four fields (X 100) counted, in a representative experiment out of three. * P < 0.005 versus medium control. KS cells into Matrigel, the vascularization and the recruitment of macrophages were significantly inhibited (Fig. 3, Fig. 4 (Fig. 4 B, Table VI) .
To demonstrate the presence in the Matrigel plug of cells bearing PAF-R which can be the putative targets of WEB 2170, sections of the gel were stained with anti-PAF-R antibody. Fig.  6 shows that PAF-R was expressed on the surface of EC lining the lumen of vessels and on leukocytes confined within the vessels.
To confirm that PAF was involved in angiogenesis induced by KS-CM, we studied the effect of synthetic PAF. The injection in mice of Matrigel containing 10 pmol of synthetic PAF was followed by a relevant angiogenic response, which was completely abolished by WEB 2170 (Fig. 4 C) . The angiogenic effect of bFGF, however, was not blocked by WEB 2170 (Table  VI) . Furthermore, PAF extracted and purified from the plasma of a patient with KS induced an angiogenic response which was blocked by WEB 2170 (Figs. 3 C and 4 F) .
Role of PAF in initiating the production of chemokines and growth factors during angiogenesis induced by KS-CM. In a (0.5 mg/ml) and injected into the abdominal subcutaneous tissue of mice along the peritoneal midline. Mice were killed at the indicated time. The Matrigel plugs were processed for immunofluorescence performed with the indicated fluoresceinated mAb. * The numbers are mean±SD of positive cells present in four microscopic fields (x 100).
6, and FGF-7. As shown in Fig. 7 , the transcripts for KC, MIP-2, PlGF, aFGF, and HGF were already present on day 2, whereas mRNA for VEGF-l and bFGF were detectable only on day 7 . mRNA of JE, FGF-3, K-FGF, FGF-5, FGF-6, and FGF-7 was always undetectable in Matrigel plugs ( Fig. 7 and not shown). The amount of RNA in control plugs was at least 50-fold lower than that detected in Matrigel plugs containing KS-CM. However, the transcripts of the studied chemokines and growth factors were absent in the pooled RNA extracted from five different control plugs (not shown). It was important to establish whether cytokine and growth factor gene expression induced by KS-CM in Matrigel plug was accompanied by production of these molecules. As shown in Fig. 6 , histological sections of Matrigel plugs were stained by immunofluorescence (Fig. 7) in the Matrigel containing KS-CM as well as the production of bFGF (Fig. 6 F) .
Discussion
KS is a highly vascularized neoplasm, the nature of which is still an enigma (8, 13) . The ontogenetic origin of KS has not been unequivocally defined (8) (9) (10) (11) (12) . Spindle cells represent the core of the lesion and consist of at least two populations, one expressing fibro-endothelial markers and the other a phenotype typical of monocytoid cells (11) . Furthermore, they also express smooth muscle a-actin (58, 59) . The existence of a mesenchymal progenitor of vascular cells (58) , which could be stimulated to grow as a consequence of cytokine imbalance, has been postulated. Some experimental observations indicate that angiogenesis is a relevant process leading to progression of the lesion. KS cells produce factors which cause an angiogenic response (33, 34) . Furthermore, angiogenic factors and a receptor for FGF are highly expressed in vivo in KS (26, (35) (36) (37) (38) . Sulfated polysaccharide peptidoglycan, which inhibits the in vitro growth of EC and KS cells, also reduces in vivo the angiogenesis and the proliferative lesions induced by KS cells (7); IFN-a, a cytokine used in the management of infantile hemangiomas, is also used in the treatment of KS (79) .
The data reported herein suggest that PAF is produced by KS cells and that it has autocrine effects on KS cells and paracrine effects on EC and VSMC. This conclusion is based on the following observations: (a) unstimulated KS cells contain low amounts of PAF which accumulate in conditioned medium after long-term incubation; (b) synthesis of PAF was increased by Thr and by inflammatory cytokines, which also enhanced the release of the mediator; (c) the amount of PAF produced by KS cells is sufficient to activate the PAF-R and elicit a As reported for EC (44) (45) (46) (47) (48) , KS cells are capable either of a rapid or delayed synthesis of PAF depending on the nature of the stimuli. Thr caused a rapid synthesis of this mediator, whereas IL-1 and TNF induced a delayed synthesis. This suggests an ontogenic relationship between KS and EC differentiation pathways. The levels of cytokines that induced PAF synthesis were shown to be increased in HIV-1 -infected patients with KS (2). In addition, clinical studies using TNF for the treatment of KS revealed that this cytokine exacerbates the disease (80) .
We also demonstrated that PAF induced directed (chemotaxis) and random (chemokinesis) migration of KS cells, through interaction with its specific receptor expressed at their surface, since the PAF-R antagonist WEB 2170 showed an inhibitory effect. Similar migratory responses were observed for EC and VSMC. These data are consistent with the morphological alterations and the redistribution of cytoskeletal proteins caused by PAF in EC (53, 55) .
A crucial step in the sequence of events that leads to the angiogenic response is the invasion of the perivascular matrix by sprouting EC. The process includes firstly motility and production of lytic enzymes enabling extracellular matrix penetration and then proliferation of EC. Many angiogenic factors stimulate the migration of EC in vitro, but not their proliferation (81) . It was reported that TNF, which inhibits in vitro EC proliferation, has angiogenic properties in vivo (82) . We recently suggested that PAF is a secondary mediator for TNF-ainduced angiogenesis (65). Herein, we brought evidence that PAF containing KS-CM was able to stimulate EC migration and to promote angiogenesis in the mouse. Moreover PAF extracted and purified from plasmas of two classical KS was found to be angiogenic. The angiogenic and migratory effects of KS-CM were inhibited in a dose-dependent manner by the specific PAF-R antagonist, WEB 2170 (66) . The minimal concentration of WEB 2170 active in vivo by intraperitoneal administration (3 mg/kg/die) or when administered in a single dose inside the Matrigel ( 100 j.sg/ml) was 5 S0-fold higher than that effective in vitro on cell migration (Table I and Fig. 2 ), but similar to that active in other animal experimental models (66, 83, 84) . WEB 2170 belongs to the family of hetrazepinoic PAF-R antagonists (66) derived from the hypnotic drug brotizolam. However, the affinity of WEB 2170 for the central benzodiazepine receptor is several hundredfold less than that of brotizolam, whereas the calculated Kd for PAF-R is similar whether PAF or WEB 2170 is used as ligand (66, 83 2170 to the PAF-R is stereospecific, the (-) optical enantiomer being more potent in inhibiting PAF-induced platelet aggregation (84) . Furthermore, at the concentrations used in vivo and in vitro in this study, WEB 2170 did not block the action of other soluble mediators (66) or the angiogenic effect of bFGF (Table VI) . The angiogenic response to KS-CM is also characterized by the expression of genes for chemokines such as MIP-2 (71) and KC (64) and angiogenic factors, including VEGF-1 (68, 77, 78) , aFGF and bFGF (73, 81) , HGF (60), P1GF (84, 85) , and KC, the murine counterpart of 11L-8 (86) . The expression of other members of FGF family, (e.g., FGF-3/int-2, FGF-4, FGF-5, and FGF-6) which can be expressed in KS lesions other than aFGF and bFGF (35) (36) (37) (38) , was not induced by KS-CM.
MIP-2, KC, P1GF, aFGF, and HGF transcripts were already present on day 2, whereas mRNA of VEGF and bFGF appeared on day 7, suggesting that KS-CM triggers sequential events leading to a progressively amplified angiogenic process. In this respect, we observed that infiltrating cells, but not EC, were VEGF immunopositive. In addition, the VEGF receptor encoded byflk-J gene, which is specific for endothelium (77, 78) , was present on EC lining the new vessels. This result suggests that, in this model, VEGF and its receptor are implicated in the process of amplification. We can speculate that bFGF and aFGF have a similar role, since we observed that infiltrating cells produced bFGF. The KS-CM cellular targets which produce chemokines and angiogenic growth factor(s) are unknown. However, we found that KS-CM induced a prominent infiltration of macrophages, which can produce VEGF (87) and bFGF (88) . With regard to chemokines, both EC and macrophages can be producers (revised in reference 89). The PAF-R antagonist WEB 2170 prevented the recruitment of macrophages and the expression of genes for chemokines and growth factors as well as the production of bFGF within Matrigel containing KS-CM. Further, WEB 2170 blocked the PAF-induced in vitro migration of a macrophage cell line. Therefore, these results suggest that PAF is chronologically one of the first mediators which triggers the angiogenesis process caused by KS-CM. Our results do not elucidate how PAF upregulates the expression of growth factors and chemokines in angiogenesis. However, it has been reported that PAF modulates cytokine (90, 91) and enzyme (92) expression by regulating transcription (93).
PAF produced by KS cells and present in KS-CM may be expected to induce angiogenesis in two ways: directly, by serving as an EC motogen and inductor of functions related to angiogenesis, and indirectly, by attracting macrophages and thereby promoting the production of angiogenic factors (89) .
This model of angiogenesis induced by KS-CM is supported by some observations done on KS. It has been demonstrated that FGFs (35) (36) (37) (38) , PDGF (26) , HGF (40) , and VEGF (39) participate in angiogenesis associated with KS, since their transcripts have been detected in vivo in the lesion or in vitro in KS cells (26, (35) (36) (37) (38) . Further, KS cells express appreciable amounts of the chemokine IL-8 and monocyte chemotactic protein-i, which are augmented by IL-1 or TNF (94) . Monocyte chemotactic protein-i expression is also present in KS lesions (94) and can explain the presence of the prominent leukocyte infiltration in KS lesions (8, 33) .
It is conceivable that the development of KS is due to an imbalance in the network of soluble mediators acting on progressive steps. Oncostatin M, IL-6, and other molecules produced by HIV-1 -infected lymphomononuclear cells or Tat protein can induce a hypothetical precursor to differentiate into spindle cells (24, 25, (27) (28) (29) (30) and sustain the growth of these "transformed cells." At the same time, mediators released by spindle cells, including PAF, may implement the angiogenic response and the recruitment of leukocytes. The final step is the release of angiogenic growth factors by the inflammatory infiltrate which amplify both the growth and the vascularization of KS lesions.
In the model here described, EC and leukocytes express PAF-R and can be the targets for the inhibitory effect of WEB 2170 on angiogenesis induced by KS-CM. The in vitro experiments indicate that WEB 2170 inhibited the migration of EC and a murine macrophage cell line induced by KS-CM, whereas it was less effective on KS cell migration. Moreover, the results of this study suggest that the pharmacological blockade of PAF-R can be useful in the control of mechanisms leading to the angiogenesis and the leukocyte infiltration in KS.
